JP2007535471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535471A5 JP2007535471A5 JP2006509122A JP2006509122A JP2007535471A5 JP 2007535471 A5 JP2007535471 A5 JP 2007535471A5 JP 2006509122 A JP2006509122 A JP 2006509122A JP 2006509122 A JP2006509122 A JP 2006509122A JP 2007535471 A5 JP2007535471 A5 JP 2007535471A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- binds
- library
- cll
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/379,151 US7435412B2 (en) | 2000-12-08 | 2003-03-04 | Chronic lymphocytic leukemia cell line |
| US10/379,151 | 2003-03-04 | ||
| US10/736,188 US20040198661A1 (en) | 2000-12-08 | 2003-12-15 | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US10/736,188 | 2003-12-15 | ||
| PCT/US2004/006577 WO2004078938A2 (en) | 2003-03-04 | 2004-03-04 | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007535471A JP2007535471A (ja) | 2007-12-06 |
| JP2007535471A5 true JP2007535471A5 (cg-RX-API-DMAC7.html) | 2008-01-24 |
Family
ID=32965320
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509122A Pending JP2007535471A (ja) | 2003-03-04 | 2004-03-04 | 慢性リンパ性白血病細胞由来のポリペプチド及び抗体並びにそれらの関連する適用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040198661A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1606388A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007535471A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050108381A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2517968A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004078938A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002246632B2 (en) * | 2000-12-08 | 2007-04-05 | Alexion Pharmaceuticals, Inc. | Chronic lymphocytic leukemia cell line and its use for producing an antibody |
| US7408041B2 (en) * | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US20060057651A1 (en) * | 2000-12-08 | 2006-03-16 | Bowdish Katherine S | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US9249229B2 (en) * | 2000-12-08 | 2016-02-02 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| JP4381140B2 (ja) * | 2001-10-12 | 2009-12-09 | シェーリング コーポレイション | 免疫応答を調節するための二重特異性抗体の使用 |
| AU2012211347B9 (en) * | 2004-07-20 | 2015-06-18 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| EP2463305B1 (en) * | 2006-01-12 | 2016-05-11 | Alexion Pharmaceuticals, Inc. | Antibodies to OX-2/CD200 and uses thereof |
| WO2008089022A2 (en) * | 2007-01-11 | 2008-07-24 | Boehringer Ingelheim International Gmbh | Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts |
| US8252286B2 (en) | 2007-05-21 | 2012-08-28 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| DK2164514T3 (en) | 2007-05-21 | 2017-02-27 | Alderbio Holdings Llc | Antibodies to IL-6 and its use |
| US8404235B2 (en) | 2007-05-21 | 2013-03-26 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US8178101B2 (en) | 2007-05-21 | 2012-05-15 | Alderbio Holdings Inc. | Use of anti-IL-6 antibodies having specific binding properties to treat cachexia |
| US9701747B2 (en) | 2007-05-21 | 2017-07-11 | Alderbio Holdings Llc | Method of improving patient survivability and quality of life by anti-IL-6 antibody administration |
| US8062864B2 (en) | 2007-05-21 | 2011-11-22 | Alderbio Holdings Llc | Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies |
| US7906117B2 (en) | 2007-05-21 | 2011-03-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| CA2694121C (en) * | 2007-07-25 | 2016-06-07 | Alexion Pharmaceuticals, Inc. | Methods and compositions for treating autoimmune disease |
| US8323649B2 (en) | 2008-11-25 | 2012-12-04 | Alderbio Holdings Llc | Antibodies to IL-6 and use thereof |
| US8992920B2 (en) | 2008-11-25 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of arthritis |
| US8420089B2 (en) | 2008-11-25 | 2013-04-16 | Alderbio Holdings Llc | Antagonists of IL-6 to raise albumin and/or lower CRP |
| US9212223B2 (en) | 2008-11-25 | 2015-12-15 | Alderbio Holdings Llc | Antagonists of IL-6 to prevent or treat thrombosis |
| KR20110091780A (ko) * | 2008-11-25 | 2011-08-12 | 앨더 바이오파마슈티컬즈, 인코포레이티드 | 악액질, 쇠약, 피로 및/또는 발열을 예방하거나 치료하는 il6의 길항제 |
| US9452227B2 (en) | 2008-11-25 | 2016-09-27 | Alderbio Holdings Llc | Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments |
| US8337847B2 (en) | 2008-11-25 | 2012-12-25 | Alderbio Holdings Llc | Methods of treating anemia using anti-IL-6 antibodies |
| MX356367B (es) | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| EP2477658A2 (en) * | 2009-09-16 | 2012-07-25 | Duke University | Hiv-1 antibodies |
| US9775921B2 (en) | 2009-11-24 | 2017-10-03 | Alderbio Holdings Llc | Subcutaneously administrable composition containing anti-IL-6 antibody |
| EP2504032A4 (en) | 2009-11-24 | 2013-06-19 | Alderbio Holdings Llc | IL-6 ANTAGONISTS FOR PREVENTING OR TREATING THROMBOSIS |
| JP6012473B2 (ja) | 2010-01-11 | 2016-10-25 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 抗cd200抗体を用いたヒトの処置における免疫調節効果のバイオマーカー |
| NZ601580A (en) | 2010-02-11 | 2014-11-28 | Alexion Pharma Inc | Therapeutic methods using anti-cd200 antibodies |
| US8992908B2 (en) | 2010-11-23 | 2015-03-31 | Alderbio Holdings Llc | Anti-IL-6 antibodies for the treatment of oral mucositis |
| TW201244737A (en) | 2011-02-03 | 2012-11-16 | Alexion Pharma Inc | Use of an anti-CD200 antibody for prolonging the survival of allografts |
| US11492383B2 (en) | 2011-06-24 | 2022-11-08 | Stephen D. Gillies | Light chain immunoglobulin fusion proteins and methods of use thereof |
| KR102379464B1 (ko) | 2016-06-20 | 2022-03-29 | 키맵 리미티드 | 항-pd-l1 항체 |
| WO2019067499A1 (en) | 2017-09-27 | 2019-04-04 | Alexion Pharmaceuticals, Inc. | BIOMARKER SIGNATURE FOR PREDICTING A TUMOR RESPONSE TO ANTI-CD200 THERAPY |
| US12139533B2 (en) | 2017-12-20 | 2024-11-12 | Alexion Pharmaceuticals, Inc. | Liquid formulations of anti-CD200 antibodies |
| US11802154B2 (en) | 2017-12-20 | 2023-10-31 | Alexion Pharmaceuticals, Inc. | Humanized anti-CD200 antibodies and uses thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3940475A (en) * | 1970-06-11 | 1976-02-24 | Biological Developments, Inc. | Radioimmune method of assaying quantitatively for a hapten |
| US4289747A (en) * | 1978-12-26 | 1981-09-15 | E-Y Laboratories, Inc. | Immunological determination using lectin |
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5225539A (en) * | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5223409A (en) * | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5427908A (en) * | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| DE69129154T2 (de) * | 1990-12-03 | 1998-08-20 | Genentech, Inc., South San Francisco, Calif. | Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften |
| US5780279A (en) * | 1990-12-03 | 1998-07-14 | Genentech, Inc. | Method of selection of proteolytic cleavage sites by directed evolution and phagemid display |
| DE69226871T3 (de) * | 1991-06-27 | 2009-09-24 | Bristol-Myers Squibb Co. | CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung |
| US5508717A (en) * | 1992-07-28 | 1996-04-16 | Sony Corporation | Computer pointing device with dynamic sensitivity |
| ATE219376T1 (de) * | 1996-03-20 | 2002-07-15 | Bristol Myers Squibb Co | Verfahren zur inhibierung der immunreaktion durch blockierung der gp39/cd40 und ctla4/cd28/b7 routen und zusammensetzung zu deren verwendung |
| US6011138A (en) * | 1997-02-20 | 2000-01-04 | Idec Pharmaceuticals Corporation | Gamma-1 anti-human CD23 monoclonal antibodies |
| PT1032662E (pt) * | 1997-11-07 | 2006-07-31 | Trillium Therapeutics Inc | Metodos e composicoes para imunomodulacao. |
| US6955811B2 (en) * | 1997-11-07 | 2005-10-18 | Trillium Therapeutics Inc. | Methods of inhibiting immune response suppression by administering antibodies to OX-2 |
| US7223729B2 (en) * | 1997-11-07 | 2007-05-29 | Trillium Therapeutics Inc. | Methods of treating allergy by administering a CD200 protein |
| US20020192215A1 (en) * | 1999-04-13 | 2002-12-19 | Schering Corporation, A New Jersey Corporation | Novel uses of mammalian OX2 protein and related reagents |
| CA2403393A1 (en) * | 2000-03-17 | 2001-09-20 | Reginald M. Gorczynski | Methods and compositions for immunoregulation |
| US7306801B2 (en) * | 2000-05-15 | 2007-12-11 | Health Research, Inc. | Methods of therapy for cancers characterized by overexpression of the HER2 receptor protein |
| CA2417874C (en) * | 2000-08-03 | 2012-10-02 | Transplantation Technologies Inc. | Use of ox-2 inhibitors for the treatment of cancer |
| US20030017491A1 (en) * | 2000-09-14 | 2003-01-23 | Zuo-Rong Shi | Chromogenic in situ hybridization methods, kits, and compositions |
| AU2002223338B2 (en) * | 2000-11-22 | 2007-06-07 | Trillium Therapeutics Inc. | Truncated CD200 |
| AU2002246632B2 (en) * | 2000-12-08 | 2007-04-05 | Alexion Pharmaceuticals, Inc. | Chronic lymphocytic leukemia cell line and its use for producing an antibody |
| US7408041B2 (en) * | 2000-12-08 | 2008-08-05 | Alexion Pharmaceuticals, Inc. | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof |
| US6953417B2 (en) * | 2003-11-17 | 2005-10-11 | Borgwarner Inc. | Method for controlling a dual clutch transmission |
| JP2007518827A (ja) * | 2004-02-02 | 2007-07-12 | シェーリング コーポレイション | Cd200およびcd200rを調節する方法 |
-
2003
- 2003-12-15 US US10/736,188 patent/US20040198661A1/en not_active Abandoned
-
2004
- 2004-03-04 KR KR1020057016376A patent/KR20050108381A/ko not_active Ceased
- 2004-03-04 JP JP2006509122A patent/JP2007535471A/ja active Pending
- 2004-03-04 CA CA002517968A patent/CA2517968A1/en not_active Abandoned
- 2004-03-04 EP EP04717403A patent/EP1606388A4/en active Pending
- 2004-03-04 WO PCT/US2004/006577 patent/WO2004078938A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102639564B (zh) | 抗-cmet抗体及其用于癌症的检测和诊断的用途 | |
| JP2019116474A5 (cg-RX-API-DMAC7.html) | ||
| JP4280803B2 (ja) | 慢性リンパ性白血病細胞株および抗体を産生するためのその使用 | |
| JP2009517057A5 (cg-RX-API-DMAC7.html) | ||
| CN103827144B (zh) | 新的抗cxcr4抗体及其用于检测和诊断癌症的用途 | |
| JP2020522513A5 (cg-RX-API-DMAC7.html) | ||
| JP7245358B2 (ja) | 抗cd25抗体及びその適用 | |
| JP2021520208A5 (cg-RX-API-DMAC7.html) | ||
| JP2013506428A5 (cg-RX-API-DMAC7.html) | ||
| JP2012176953A5 (cg-RX-API-DMAC7.html) | ||
| KR20130100963A (ko) | 암의 진단 및/또는 예후를 위한 새로운 항체 | |
| WO2006020266A2 (en) | Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof | |
| JP2021517152A5 (cg-RX-API-DMAC7.html) | ||
| JP2009509538A5 (cg-RX-API-DMAC7.html) | ||
| WO2013017562A1 (en) | Use of the antibody i-3859 for the detection and diagnosis of cancer | |
| JP2023157927A (ja) | 多発性骨髄腫におけるmタンパク質反応の臨床評価 | |
| WO2017114973A1 (en) | Compositions and methods for assessing the risk of cancer occurrence | |
| US12091457B2 (en) | Use for preventing and treating myeloid-derived suppressor cell-related diseases | |
| JP2020515286A5 (cg-RX-API-DMAC7.html) | ||
| US20240117042A1 (en) | Immunohistochemistry methods and kir3dl2-specific reagents | |
| WO2016174053A1 (en) | Igf-1r antibody and its use for the diagnosis of cancer | |
| US20230192900A1 (en) | Bispecific antibodies binding hvem and cd9 | |
| JP2023516705A5 (cg-RX-API-DMAC7.html) | ||
| JP2021516989A5 (cg-RX-API-DMAC7.html) | ||
| JP7821779B2 (ja) | 抗体を使用した細胞表面mica及びmicbの検出 |